October 31st 2024
Learn more about the in-depth topics covered in the October 2024 print issue of Dermatology Times.
Motivators like health benefits, altruism, and trust in clinicians enhance participant retention and adherence in melanoma research, according to MEL-SELF findings.
Dermatology Times is looking back on the top stories in dermatology from the month of October.
Dermatology Times is recapping our top expert interviews from the month of October.
October 30th 2024
A pilot study monitored the disease management, technical challenges, and overall benefits for chronic spontaneous urticaria.
Pointers With Portela: Minimalist Skin Care Routines
In this week’s Pointers With Portela, the 208SkinDoc discusses the effectiveness of a minimalist anti-aging skin care routine for patients.
New Dermatology Social Comparison Scale Demonstrates Acceptable Psychometrics for Clinical and Research Applications
Researchers recently developed and validated the 3-question social comparison scale, which may be applicable outside of conditions such as eczema and psoriasis.
Experts Pen 12 Implementable Steps For Addressing Gender Inequity In Academic Dermatology
Addressing gender inequity in academic dermatology involves strengthening societies, celebrating female dermatologists, promoting leadership, and equitable representation, authors wrote.
A Novel Approach to Distinguishing Scabies From Atopic Dermatitis
The WHO underscores the significance of addressing scabies as a neglected skin disease, especially in regions with limited health care access.
In Interim Analysis, Mogamulizumab Demonstrates Improvements In Mycosis Fungoides, Sézary Syndrome
Interim findings from the PROSPER study of mogamulizumab in adults with CTCL were recently presented orally.
Dermatology Residency Programs Lack Specific, Comprehensive Education on Sensitive Skin
Research from the GW School of Medicine and Health Sciences was recently published in the Journal of Drugs in Dermatology.
Partner Q&A: Spherix Global Insights' Role in Shaping the Future of Dermatology
Dermatology Times is pleased to introduce one of our newest partners, Spherix Global Insights. Learn more about their vision and plans to leverage knowledge to support dermatology.
Derm In The News: April 7-13
Keep up with the latest headlines in dermatology from the past week, including UK efforts to address skin cancer disparities in skin of color, efficacy of a "virtual biopsy," and more.
The Weekly Roundup: April 8-12
ICYMI, this week we had news about Rosacea Awareness Month, topical pravibismane in diabetic foot ulcer infections, and more.
Meet the Spring Editor in Chief: Aaron Farberg, MD
Dermatology Times is pleased to introduce our Spring Editor in Chief, Aaron Farberg, MD, with a snapshot of his involvement in the dermatology space.
Journal Digest: April 8
This week’s collection of the latest dermatologic studies covers circulating tumor DNA in advanced cSCC, targeting IL-13 with tralokinumab in AD, a pediatric lymphoplasmocytic plaque case report, and skin of color reporting in randomized controlled trials focusing on SCC.
Springing Into the Latest Research in Dermatology
In an introduction to our April publication, explore an overview of topics covered in this issue and an introduction to our Spring Editor in Chief, Aaron Farberg, MD.
Phase 1b Data for Topical Pravibismane in Diabetic Foot Ulcer Infection Demonstrates Favorable Effects and Safety
Data was recently published in the International Wound Journal supporting positive outcomes in moderate or severe ulcers.
Derm In The News: March 31-April 6
Keep up with the latest headlines in dermatology from the past week, including the launch of an expanded job board for dermatology support roles, CMS and Incyte's collaboration for povorcitinib in China and Southeast Asia, and more.
The Weekly Roundup: April 1-5
ICYMI, this week we had news about Ycanth's J-code launch, highlights from Diversity in Dermatology, bimekizumab's accepted sBLA for HS, and more.
Increased Levels of B-Type Natriuretic Peptide May be Associated With Various Types of Chronic Itch
Gil Yosipovitch, MD, discusses the correlation between increased BNP levels and chronic pruritus of unknown origin.
Topical Permethrin Demonstrates Lack of Efficacy Compared to Benzyl Benzoate in Most Scabies Cases
In a comparative study, benzyl benzoate demonstrated superior efficacy in scabies cases, while topical permethrin exhibited a lack of effectiveness.
Omalizumab for Chronic Spontaneous Urticaria Does Not Yield Negative Maternal, Fetal Outcomes in Pregnancy
Researchers reviewed the efficacy and safety of omalizumab in patients with severe CSU in a routine clinical practice setting.
Journal Digest: April 4
This week’s collection of the latest dermatologic studies covers topical permethrin 5% vs. benzyl benzoate 25% for scabies, the safety of omalizumab in CSU during pregnancy, symptoms of cognitive impairment in children with AD, and the ethics of cosmetic overtreatment.
New Data on Retinol: Patricia Farris, MD, Shares Insights on Anti-Aging
In this study, topical 0.1% retinol significantly improved crow’s feet, facial wrinkles, uneven skin tone, brown spots, and overall photoaging.
Pointers With Portela: Effects of Hormone Changes on the Skin
In this week’s Pointers With Portela, the 208SkinDoc reviews how the skin is affected during hormonal changes and menopause.
Pelthos Therapeutics Launches to Accelerate Commercialization of Treatment for Molluscum Contagiosum
The new launch is set to bring berdazimer topical gel, 10.3% to adults and pediatric patients over the age of 1 with molluscum contagiosum faster.
Soligenix and European Medicines Agency Settle on Design of Second Placebo-Controlled Trial of HyBryte in CTCL
The agreement for a second confirmatory trial comes after a successful phase 3 FLASH study that yielded positive outcomes and efficacy.
Muneeb Shah, DO: Behind the Scenes of Launching a Skin Care Brand
Shah discusses the science behind his products, as well as the challenges he didn’t anticipate when launching Remedy.
Recapping March Dermatology Biosimilar News
The biosimilar landscape experienced significant activity, marked by fresh data from conferences, novel findings regarding adalimumab biosimilars, and more.
Mona Shahriari, MD, FAAD: 'The Days of Paternalistic Medicine Are Gone'
Shahriari shares pearls and considerations from her sessions at the recent Diversity in Dermatology conference.
Incyte and CMS Collaborate to Develop Povorcitinib in Numerous Chinese Regions
Povorcitinib is being evaluated for non-segmental vitiligo, hidradenitis suppurativa, prurigo nodularis, asthma, and chronic spontaneous urticaria.
J-Code for Ycanth Officially Launches Today
The permanent J-code for the molluscum contagiosum treatment is now live.
The Weekly Roundup: March 25-29
ICYMI, this week we had news about bringing awareness to ethics in aesthetics, the 7 year anniversary of dupilumab's approval for atopic dermatitis, and more.
EltaMD Rings Bell at New York Stock Exchange as Continued Celebration of National Dermatologist Day
EltaMD representatives and dermatologists partook in the celebration on March 28 as a continuation of the celebration and momentum of the newly-established National Dermatologist Day.